Neuroimaging

Atlanta, Georgia, August 20, 2026 Alzamend Neuro, Inc. has announced that data from its Phase 1/2A clinical trial of...

GUILFORD, Conn., July 30, 2026 Hyperfine, Inc. announced the publication of multiple peer-reviewed clinical studies highlighting the expanding role...

MENLO PARK, California, July 13, 2026 PharmatrophiX, in collaboration with Indiana University School of Medicine, has presented encouraging new...

VANCOUVER, British Columbia, July 6, 2026 Grey Matters Health Inc. announced the delivery of its first FDA-cleared CareMiBrain™ brain-dedicated...

Seoul, South Korea — February 6, 2026 Neurophet has announced that the U.S. Food and Drug Administration (FDA) has...